Kacper Odziomek Excels in 2 Pharmacology Courses from Harvard Medical School
Kacper Odziomek, Member of the Student Council at the Polish Space Agency SA, shared a proud post on LinkedIn:
“I am pleased to share that I have earned certificates of achievement in two Pharmacology courses from Harvard Medical School Professional, Corporate, and Continuing Education.
The Clinical Drug Development course explored the full process of bringing new therapeutics from concept to patient, with emphasis on trial design, modern adaptive methodologies, bias and confounding control, data analysis, and the ethical and regulatory frameworks that ensure patient safety.
The Drug Delivery course examined the science and engineering behind optimizing therapeutic delivery, including systemic vs. local administration, overcoming biological barriers, polymeric and nanoparticle carriers, triggerable release systems, and emerging innovations such as closed-loop delivery technologies.
The participation was financed by the Ministry of Science and Higher Education within the project “Support for students in improving their competencies and skills” carried out under the European Funds for Social Development 2021-2027 Programme (FERS.01.05-IP.08-004/23).”
Congratulations to Kacper Odziomek on this outstanding achievement!
More winner stories featured in Hemostasis Today.
-
Jan 9, 2026, 12:17Louise St Germain Bannon Invites You to Self-Nominate for the ISTH Council
-
Jan 9, 2026, 09:25Emma Groarke Shares A Comprehensive Review on VEXAS Syndrome
-
Jan 9, 2026, 09:13Anirban Sen Gupta Presents PlateChek
-
Jan 9, 2026, 08:58Oscar Pena Shares KDIGO 2026 Update: 5 Critical Changes for Anemia in CKD Management
-
Jan 9, 2026, 07:38Bartosz Hudzik on Subacute Coronary Occlusions: Navigating the Gray Zone in CAD Care
-
Jan 9, 2026, 07:27Gregory Piazza on The Role of D-Dimer in VTE Evaluation
-
Jan 9, 2026, 07:19Emmanuel J Favaloro Shares the 1st Article in a VWD Series Marking the 100-Year Anniversary
-
Jan 9, 2026, 07:07Taylor Robichaux on Recombinant ADAMTS13 Therapy in cTTP
-
Jan 9, 2026, 06:25Sara Ng: VTE Continues to Plague Modern Oncology